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Interaction of Bovine Blood Clotting Factor Va and Its Subunits with
Va and factor Va-LC for phospholipid-binding sites. (b) The
dissociation constant of protein-phospholipid interaction in-
creases with the ionic strength, whereas the maximum pro-
tein-binding capacity of the phospholipid vesicle was not af-
fected by ionic strength. (c) The dissociation constant for
factor Va-phospholipid interaction depends on pH when the
vesicle consists ofphosphatidic acid. It is concluded that factor
Va-phospholipid interaction is primarily electrostatic in nature,
where positively charged groups on the protein directly interact
with the phosphate group of net negatively charged phos-
pholipids. The results suggest that factor Va, like factor Xa
and prothrombin, has the characteristics of an extrinsic
membrane protein.
teraction (Subbaiah etal.,1976). In addition, the possibility
that the binding of factor V to membranes is mediated by
calcium ions can be ruled out (Greenquist & Colman, 197 5;
Subbaiah et al., 1976). In essence, those observations were
confirmed in a study that utilizes factor V of high purity and
a method of analysis that yields quantitative equilibrium-
binding data (Bloom et al., 1979). It was suggested that factor
Va-membrane interaction is nonelectrostatic in nature. The
role of phosphatidylserine in the protein-lipid nonelectrostatic
interaction could not be explained (Bloom et al.,1979).
The purpose of this study is to establish the mode of action
of acidic phospholipid in the factor Va-phospholipid inter-
action. We utilized large-volume unilamellar vesicles, which
can be separated from the bulk solution by centrifugation, for
determination of binding parameters of the factor Va- and
factor Va subunit-phospholipid interactions. The binding
technique presented here is a valuable tool in the study of the
effect of phospholipid composition, pH, ionic strength, and
calcium on factor Va-phospholipid interaction.
Materials and Methods
S 2238r and S 2337 were purchased from AB Kabi Diag-
nostica. Soybean trypsin inhibitor (type I-S), Echis carinata
I Abbreviations : S 2238, o-phenylalanyl-l-pipecolyl-l-arginine-p-
nitroanilide dihydrochloride; S 2337 , N-benzoyl-t--isoleucyl-r--glutamyl-
(piperidyl)-t--glycyl-l-arginine-p-nitioanilide hydrochloride; RVV-X,
factor X activator purified from Russell's viper venom; RVV-V, factor
V activator purified from Russell's viper venom; Tris, tris(hydroxy-
methyl)aminomethane; STI, soybean trypsin inhibitor; EDTA, ethyl-
enediaminetetraacetic acid; DOPS, 1,2-dioleoyl-sn-glycero-3-phospho-
serine; DOPC, 1,2-dioleoyl-sn-glycero-3-phosphocholine; DOPA, 1,2-
dioleoyl-sn-glycero-3-phosphatidic acid; LC, light chain; HC, heavy
chain.
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Phospholipid Vesiclest
Piet van de Waart,I Harry Bruls, H. Coenraad Hemker, and Theo Lindhout*
ABSTRAcT: Thrombin-activated factor Va and factor Va
subunit binding to large-volume vesicles was investigated by
a technique based on the separation by centrifugation of
phospholipid-bound protein from the bulk solution. This
technique allows the direct measurement of free-protein con-
centration. It is concluded that the phospholipid binding site
on factor Va is located on a basic factor Va subunit with M,
80000 (factor Va-LC). The effects of phospholipid vesicle
composition, calcium concentration, pH, and ionic strength
on the equilibrium constants of factor Va- and factor Va-
LC-phospholipid interaction were studied. Factor Va and
factor Va-LC binding to phospholipid requires the presence
of negatively charged phospholipids. It is further demonstrated
that the following occur: (a) Calcium ions compete with factor
r|.!
Ihe prothrombinase complex catalyzes the proteolytic con-
version of the zymogen prothrombin to the serine protease
thrombin. The components that constitute the complex are
factor Xa (the catalytic component), calcium ions, phospho-
lipid, and factor Va [see Jackson & Nemerson (1980) for a
reviewl. Factor Va, which is derived by limited proteolysis
of a single-chain precursor of M.330000, functions as a co-
factor (Esmon, 1979; Nesheim & Mann, 1979). The effects
of factor Va and phospholipids on the kinetic parameters of
prothrombin activation have given insight in the mode of action
of nonenzymatic cofactors in prothrombin activation (Rosing
et  a l . ,  1980).
Knowledge of the molecular details of the assembly of the
prothrombinase complex is of importance in order to under-
stand the mechanism of prothrombin activation at a phos-
pholipid-water interface. From the studies reported by
Nelsestuen and co-workers, a detailed model of the pro-
thrombin- and factor Xa-membrane complex:s can be drawn
(Lim et al., 1977; Resnick & Nelsestuen, 1980; Wei et al.,
1982).
The nature of the factor Va-phospholipid interaction has
still to be disclosed. In most previous studies, gel filtration
has been used to elucidate the factor V(a)-phospholipid-
binding characteristics. On the basis of these qualitative
studies, it appeared essential to have net negative charged
phospholipids in the membrane for factor V-membrane in-
l From the Department of Biochemistry, Biomedical Center, Rijksu-
niversiteit Limburg, Maastricht, The Netherlands. Receiued Nouember
2 ,1982 .
IP.v.d.W. was supported by the Netherlands Organization for the
Advancement of Pure Scientific Research (Z.W.O.).
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venom, Russell's viper venom, ovalbumin, and 1,2-dioleoyl-
sn-glycero-3-phosphocholine (DOPC) were obtained from
Sigma. N-Succinimidyl 3-(4-hydroxy-5-[t25I]iodophenyl)-
propionate was from Amersham.
The following bovine blood coagulation factors were pre-
pared: factor X2 (Fujikawa et al., 1972a), factor Xa (Fujikawa
et al., 1972b), prothrombin (Owen et al., 1974), thrombin
(Rosing et al., 1980), and factor V and factor Va (Lindhout
et a1., 1982). RVV-V was isolated as described by Kisiel
(1979). l2sl-Labeled factor V was prepared according to
Bolton & Hunter (1973) using l0 mCi of t"Il^g of protein.
The specific radioactivity of l2sl-labeled factor V was 2610
cpm/ng (0.4 mol of r25l/mol of factor V). l2sl-Labeled factor
V retained about 90Vo of its activity and had the same elec-
trophoretic mobility on sodium dodecyl sulfate (NaDodSOa)
gel electrophoresis prior to and after labeling.
Protein Concentrations. Determination of prothrombin by
enzymatic assay was carried out after conversion to thrombin.
Typically, 5-100 nM prothrombin in 50 mM Tris-100 mM
NaCl-O.S mg of ovalbuminlmL (pH 7.5) was incubated with
Echis carinata venom (4 pglmL) for l0 min at 37 oC. Within
this time, complete conversion of prothrombin into thrombin
was obtained. The molar concentration of thrombin formed
was measured as described by Rosing et al. (1980). The
concentration of prothrombin as determined by the enzymatic
assay agrees very well with that calculated from the ̂ 86 with
EL?o = 15.5 and 72000 for the molecular weight of pro-
thrombin (Owen et al., 1974). The concentration of factor
Xa was determined as described by van Dieijen et al. (1981).
The factor Va assay is based on the formation of an
equimolar factor Va-factor Xa complex as the catalytic unit
in prothrombin activation (Lindhout et al., 1982). Under
conditions where factor Xa is far in molar excess over factor
Va, the rate of prothrombin activation is linear with the
concentration of factor Va. A factor Va containing sample
after the appropriate dilution in 50 mM Tris-100 mM NaCl-5
mM CaCl2-0.5 mg of ovalbumin/ml (pH 7.5) was incubated
with factor Xa (1.3 x l0-rr M), phospholipid (20Vo DOPS/
807o DOPC, l0 rlM), and CaCl2 (5 mM) in 50 mM Tris-100
mM NaCl-0.5 mg of ovalbumin/ml (pH 7.5) for 5 min at
37 oC in a plastic cuvette. Prothrombin activation was started
by the addition of 0.1 mL of prothrombin (2 pM). The final
volume is 1.0 mL. After 2 min, the reaction was stopped by
the addition of 1.0 mL of buffer containing 50 mM Tris-I00
mM NaCl{).5 mg of ovalbumin/ml-20 pg of STI-{.47 lrmol
of S 2238 (pH 7.5). The amount of thrombin formed was
measured by the change in absorbance recorded on an Aminco
DW-2 spectrophotometer operating in the dual-wavelength
mode (tr" = 405 nm and tr, = 500 nm) thermostated at3l "C.
Standard curves were constructed by assaying dilutions of a
factor Va preparation of which the concentration was deter-
mined by titration with active site titrated factor Xa (Lindhout
et al., 1982). The assay had a functional range from 2 x 1trr4
to 1.0 X 10-12 M of factor Va. The functional factor Va
concentration was about 95Vo of the concentration as deter-
mined from.E2ro with ELTo = g.S and 330000 for the molecular
weight of unfractionated factor Va (Nesheim et al., 1979).
The concentration of factor V was determined by the factor
Va assay after activation with thrombin. Typically, the ac-
tivation reached completion within l0 min at 37 oC with a
factor V:thrombin molar ratio of 200:1.
The concentration of factor Va-LC was estimated by its
ability to restore factor Va activity when incubated with factor
Va-HC in the presence of calcium (Lindhout et al., 1982).
Since neither one of the polypeptide chains of which factor
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Va is composed exhibits factor Va activity, maximum factor
Va activity, as a result of saturation of factor Va-LC with
factor Va-HC, gives the molar concentration of factor Va-LC
preparations from a factor Va standard curve. If one knows
the specific radioactivity (cpm/pmol), the molar concentration
of l25l-labeled factor Va-LC can be estimated from radioac-
tivity measurements.
Phospholipid and Phospholipid Vesicle Preparation. 1,2-
Dioleoyl-sz-glycero-3-phosphoserine (DOPS) and 1,2'
dioleoyl-sn-glycero-3-phosphatidic acid (DOPA) were prepared
from 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) as
described by Comfurius & Zwaal (19'77). Sonicated vesicle
solutions were prepared from mixtures of DOPS and DOPC
in a buffer containing 50 mM Tris-l00 mM NaCl (pH 7.5)
as described by de Kruijff et al. (1975) with a MSE Mark II
ultrasonicator set at 7-p amplitude.
Large-volume vesicles were prepared by a modification (Van
der Steen et a1., 1 98 I ) of the ether-injection method according
to Deamer & Bangham (1976). These large (300-nm diam-
eter) vesicles are unilamellar (Van der Steen et al., 1981). In
case the vesicles were used in ionic strength studies, the buffer
contained the appropriate NaCl concentration. In order to
remove residual ether, it was necessary to dialyze the vesicle
solutions overnight at 4 "C with several changes of buffer.
Large membrane structures were removed by centrifugation
for 10 min at 40009 and 20 oC. The supernatant was cen-
trifuged for 30 min at 300009 and 20 oC. The pellet was
resuspended in 50 mM Tris-100 mM NaCl (pH 7.5).
Thin-layer chromatography of the vesicle preparation as
carried out according to Broekhuyzen (1969) showed that no
alterations did occur in the membrane composition as a result
ofthe procedure ofvesicle preparation. The internal volume
of the vesicles was determined from the amount of trapped
arsenazo III, according to Serham et al. (1981). For the
trapped volume of vesicles containing 20Vo DOPS and 80Vo
DOPC, 10-14 L/mol of lipid was found, which agrees with
the value reported by Deamer & Bangham (1976). Whenever
a membrane composition is expressed as a percentage of acidic
phospholipid, the remaining phospholipid is DOPC.
Procoagulant activity of phospholipid vesicles was deter-
mined under the same conditions as described for the factor
Va assay. A phospholipid-containing sample was incubated
with factor Xa (1.3 x l0-1r M) and factor Va (5.0 x 10-10
M). Standard curves were constructed by assaying dilutions
of phospholipid of which the concentrations were determined
by phosphate analysis (Bdttcher et al., 1961). The assay had
a functional range from I to 100 nM.
Protein- Binding M easuremenls. Mixtures of large-volume
vesicles and protein (0.2-0.5 mL) were incubated in 1.5-mL
Eppendorf conical centrifuge tubes for 10 min at ambient
temperature (20-23 oC). Prior to and after centrifugation
for 30 min at 300009 and 20 "C, small aliquots (10 pL) were
withdrawn and assayed for protein as described in this section
for determination of total protein concentration and the con-
centration of unbound protein, respectively. The phospholipid
concentration in the supernatant was less then 0.1% of the total
amount added, as determined by the phospholipid procoagulant
activity assay. Care has to be taken to avoid nonspecific
binding andf or loss in activity during the experiment. Control
experiments in the absence of phospholipid established that
prior to and after centrifugation the recovery of protein was
virtually 100%. Moreover, prothrombin and factor Xa binding
by the large-volume vesicles was reversible as shown by the
addition of EDTA to dissolve the complex after centrifugation,
followed by resuspending the vesicles and a second spin down.
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Table I: Phospholipid-Binding Properties of Prothrombin,
Factor X, Factor Xa, Factor V, and Factor Va
protein
total
lipido K6
concn (x10-?)
tuM) (M)
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pholipid interaction, are higher in this study than in those by
light scattering (Bloom et al., 1979; Nelsestuen & Broderius,
1977). This may reflect some heterogeneity with respect to
the unilamellar nature of the vesicles. Light-scattering ex-
periments show that the proteins used in this study do not
induce vesicle-vesicle interaction. Therefore, an underesti-
mation of the n values seems unlikely. From these experi-
mental results we conclude that the technique presented here
is a valuable tool for the determination of equilibrium constants
for protein-lipid interaction and yields equilibrium constants
that agree very well with those determined by relative light-
scattering experiments.
IdentiJication of Phospholipid- Binding S ubunit of Factor
Va. The facts that factor Va-membrane interaction depends
on the presence of acidic phospholipids and factor Va consists
of a cationic and anionic component (Esmon, 1979) might
indicate that factor Va has a positively charged area that
directly interacts with net negatively charged phospholipid.
In order to find evidence for this hypothesis, it was first
necessary to separate the chains of factor Va. Whereas
cleavage of the RVV-V-sensitive bond results in complete
activation of factor V, activation of factor V by thrombin
requires several bond cleavages and gives rise to at least four
different fragments (Lindhout et al., 1982; Kane et al., 1982).
In order to avoid interference in our binding studies of con-
taminating radiolabeled peptides, which might be present in
the isolated subunits derived from thrombin-activated factor
Va, we prefered to study the phospholipid-binding properties
of the subunits of which RVV-V-activated factor Va is com-
posed. To this end, r2sl-labeled factor V was incubated with
RVV-V, and after completion of the reaction, the activation
fragments were separated by ion-exchange chromatography.
Factor V upon incubation with RVV-V is converted into two
polypeptide chains with M, 270000 and 80 000. A 30-fold
increase in factor Va activity was obtained. The peptides were
separated by ion-exchange chromatography (Lindhout et al.,
1982). The l,|1, 80000 and 270000 peptides eluted at 50 and
250 mM NaCl, respectively. Neither peptide possessed factor
Va activity after incubation for 2h at 37 oC in the presence
of 25 mM CaCl2. The respective specific radioactivities are
579O cpmlp,g for r2sl-labeled factor Va-HC and 1280 cpm/pg
for r2sl-labeled factor Va-LC.
The different charge properties of the peptides were studied
by isoelectrofocusing on LKB ampholine PAG plates (pH
range 3.5-9.0). The isoelectric point of factor Va-HC was
about 5.5, whereas factor Va-LC was detected at the extreme
cathodic position, indicating that the isoelectric point of factor
Va-LC must be higher than 9.0.
The binding of r2sl-labeled factor Va-LC and l2sl-labeled
factor Va-HC to vesicles containing 20VoDOPS was measured
as a function of the phospholipid concentration. Plotted in
Figure I is the percentage of added protein bound vs. the
phospholipid concentration. At the highest phospholipid
concentration, virtually no factor Va-HC was bound, whereas
half of the amount of added factor Va-LC was bound at 5 pM
phospholipid. It can be questioned whether factor Va-HC
labeling on the amino groups does not destroy lipid binding.
However, the factor Va activity that could be restored after
incubation of the supernatants of the factor Va-HC vesicle
mixtures with factor Va-LC in the presence of calcium was
independent of the phospholipid concentration. This indicates
that no detectable amounts of factor Va-HC were bound to
phospholipid vesicles. These results ascertain that the phos-
pholipid-binding site of factor Va is located on a basic factor
Va subunit with M,80000.
n b
r .9
) n
6 .0e
t . 9
l. '7
2.5e
t. ' l
2.0
2.8
2.7
0. ' l f
0.44
0.58
43t
0.63
q 20% DOPS|S0% DOPC. o Phospholipid to protein ratio at
saturation (mol/mol). c 20%PS (bovine brain)/807oPC (egg yolk)/
1% cerebrosides. a 25% Folch fraction llllTSVo soybean PC.
e Data taken from Nelsestuen & Broderius (7977'1. r Data taken
from Bloom et al. (1979).
prothrombin
factor X
factor Xa
factor V
factor Va
(thrombin activated)
factor Va
(RW-V activated)
100
50
3 5 c
50
25
3 5 c
50
25
100
50
n d
50
25
33d
50
240
25s
1 00e
91
9 l
g0e
9r
80
416
385
270t
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100
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It was also checked that phospholipid, carried over from the
reaction mixture prior to centrifugation, had no effect on the
protein assays.
Protein binding data were analyzed by double-reciprocal
plots with the following equation:
r /B= ( r /F ) (Ka /n )+ r / n
in which B and F are concentrations ofbound protein and free
protein, respectively. The dissociation constant, K6, and
maximum protein-binding capacity of the membrane, n, were
calculated from the horizontal and vertical intercepts, re-
spectively.
Results
Prothrombin-, Factor X-, Factor Xa-, Factor Y-, and
Factor Ya--Phospholipid Binding. Various amounts of protein
(0.02-0.5 pM) were incubated with large-volume vesicles
containing 20VoDOPS in 50 mM Tris-100 mM NaCl-3 mM
CaCl2-0.5 mg of ovalbumin/ml for l0 min at room tem-
perature prior to centrifugation. From the measured equi-
librium concentration of free protein, the binding parameters
were calculated as described under Materials and Methods.
The factor V binding experiments were carried out with
r2sl-labeled factor V. Different phospholipid concentrations
were used to ascertain that the binding parameters are inde-
pendent of the phospholipid concentration. The binding pa-
rameters obtained are listed in Table I, together with the values
reported for prothrombin and factor X (Nelsestuen & Bro-
derius, 1977) and factor V and factor Va (Bloom etal.,1979).
The K6 values for prothrombin, factor X, and factor Xa agree
very well with the K6 values determined from light-scattering
experiments (Nelsestuen & Broderius, 1977). ln contrast to
the data reported by Bloom etal. (1979), we found that factor
Va binds to phospholipid with about 5 times the affinity of
factor V. The reason for this difference is not known. Eight
independent factor Va-phospholipid-binding analyses, using
different factor Va and vesicle preparations, gave a dissociation
constant of (5.6 + l. l) x l0-8 M (mean + SD).
As shown in Table I, the maximum protein-binding capacity
of membranes, n, did not vary with the phospholipid concen-
tration. The a values, in particular for prothrombin-phos-
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Table II: Factor Va and Factor Va-LC Binding to Vesicles of
Varying DOPS Content
DOPS
(%)
factor Va factor Va-LC
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FrcuRE 1: Binding of l2sl-labeled factor Va-HC and r2sl-labeled factor
Va-LC as a function of phospholipid concentration. The phospholipid
is 207o DOPS in 50 mM Tris-100 mM NaCl-l mg of ovalbumin/ml
(pH 7.5). r2sl-Labeled factor Va-HC [(o),27 pclmLl or 
r2sl-labeled
factor Va-LC l(a),8.2 pglmLl was added, and free and bound protein
concentrations were estimated as described under Materials and
Methods.
K6 0rM) n a K6 0rM) n o
(  F ree  fac to r  Va )  
-1  
.  u -1 t  ro -7
FIGURE 2: Double-reciprocal plots of factor Va-phospholipid binding
at varying calcium concentrations. Free and bound factor Va con-
centrations were estimated as described under Materials and Methods.
Large-volume vesicles of 207o DOPS (20 pM) in 50 mM Tris-100
mNt NaCl-l mg of ovalbumin/ml (pH 7.5) were used. The plots
show data obtained at the following calcium concentrations: (O) 0'5
mM CaCl2; (a) 5 mM CaCl2; (r) 10 mM CaCl2.
7 l
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4 8
ND
4 0
0
5
1 0
15
20
30
no binding
0.42
0.25
0.071
o.042
0.020
no binding
0.50
0 .13
0.030
NDb
0.018
t52
1 1 5
80
75
o Phospholipid to protein ratio at saturation (mol/mol).
not determined.
b ND,
Factor Va-LC Binding as a Function of Phosphatidylserine
Content. The results of factor Va binding experiments with
vesicles of varying Folch fraction III content reported by Bloom
et al. (1979) suggest hat the binding affinity of factor Va is
directly proportional to Folch fraction III content in the region
below -25Vo Folch fraction III (or -20Vo phosphatidylserine).
To determine whether factor Va-LC-phospholipid interaction
is also dependent on the presence of acidic phospholipid, we
carried out binding experiments with large-volume vesicles of
varying DOPS content. Various amounts of 125l-labeled factor
Va-LC (0.1-1.0 pM) were incubated with 20 pM phospholipid
(DOPS content ranging from 0 to 30Vo) in 50 mM Tris-100
mM NaCl-l mM CaCl2-l mg of ovalbumin/ml (pH 7.5)
for 10 min at room temperature prior to centrifugation. The
equilibrium concentrations offree and bound r25llabeled factor
Va-LC were determined as described under Materials and
Methods. The binding parameters were calculated from
double-reciprocal plots of free factor Va-LC vs. bound factor
Va-LC. Under the same conditions, we carried out factor Va
binding experiments. The binding parameters obtained are
presented in Table II).
Factor Va and factor Va-LC do not bind to l00Vo DOPC
vesicles. It is apparent that the binding affinity ofboth factor
Va and factor Va-LC increases with an increase in the DOPS
content of the membrane. Moreover, the affinities of factor
Ya-LC and factor Va are nearly identical. The maximum
protein-binding capacity also appears to increase with the
increase of DOPS content of the membrane. Therefore, the
factor limiting both factor Va and factor Va-LC binding is
assumed to be availability of phosphatidylserine. Packing of
protein on the membrane at high phosphatidylserine content
may be a limiting factor in factor Va and factor Va-LC
- g 3
I
1 t
t
Y
1
4 6 8 1 0
c a 2 * ,  r M
rrcune 3: Summary of dissociation constants (K6) for l2sl-labeled
factor Va-LC-phospholipid binding (O) and factor Va-phospholipid
binding (o) at different calcium concentrations. The dissociation
constants calculated from double-reciprocal plots (see, e.g', Figure
2) are plotted vs. added calcium. The phospholipid vesicle composition
and phospholipid concentration are as given in Figure 2.
binding. However, our experiments do not allow further
conclusions on this subject.
Effect of Calcium on Factor Va- and Factor Va-LC-
Phospholipid Interactions. In view of the phosphatidyl-
serine-dependent binding of the net positively charged factor
Va subunit, it is of particular interest to examine the effect
of calcium on quantitative equilibrium-binding data. If the
interaction of factor Va with phospholipid is essentially an ionic
process, ionic shielding of the negatively charged phospholipid
polar head group by calcium (Hauser et a1.,1976) would have
an effect on the dissociation constant rather than on maximum
protein-binding capacity.
A factor Va binding experiment using 20Vo DOPS large-
volume vesicles at different calcium concentrations is shown
in Figure 2. Calcium ions have an effect on the dissociation
constant of factor Va-phospholipid interaction and not on the
maximum protein-binding capacity. In other words, factor
Va and calcium ions compete for binding sites on the phos-
pholipid vesicles. We were not able to determine K6 ar'd n
values for factor Va-phospholipid interaction in the absence
F
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o
I
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o
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FIcuRE 4: Effect ofpH on dissociation constants (Ki offactor Va-
and r2sl-labeled factor Va-LC-phospholipid interaction' The disso-
ciation constants were estimated from double-reciplocal plots as shown
in Figure 2. The buffer used was 50 mM Tris-100 mM NaCl-O.2
mM CaCl2-l mg of ovalbumin/ml (pH values 7-9). The two vesicle
compositioirs ar;2VoDOPS (panel A, 20 pM)-and 207o DO?A (panel
B, 25 pM). The dissociation constants for r2sl-labeled factor Va'
LC-phospholipid binding (O) and factor Va-phospholipid binding
(O) at varying pH are shown.
of exogenous Ca2+, since under this condition loss of factor
Va activity was observed. From a replot of apparent Kd values
vs. calcium concentration (Figure 3), it was calculated that
in the absence of exogenous calcium the dissociation constant
for factor Va-phospholipid interaction equals 0'045 pM. Also
shown in Figure 3 is the replot of apparent r(6 values for factor
Va-LC-membrane interaction vs' calcium concentration. It
is interesting to see that the factor Va-LC-membrane inter-
action shows a smaller sensitivity to calcium than does the
factor Va-membrane interaction.
Another explanation than ionic shielding for the observed
calcium effect must be considered. Calcium ions can induce
lateral phase separation and irreversible vesicle fusion or ag-
gregation of phospholipids. However, if vesicle fusion and/or
aggregation of phospholipid did occur, we would expect a
major effect on maximum protein-binding capacity rather than
an effect on the dissociation constant. When the order of
addition was changed, the same binding parameters were
obtained, which means that factor Va and factor Va-LC
binding to membranes is reversible.
Effect of pH on Factor Va- and Factor Va-LC-Phospho-
lipid Interactions. The effects of pH on proteinlhospholipid
interaction were studied for two different vesicle compositions:
2}VoDOPAand2}Vo DOPS. The procedures and method of
data analysis are similar to those in Figure 2.
The results for phosphatidylserine show minor changes in
K6 between pH 7 and 9 (Figure 4). In addition, the pro-
tein-binding capacity of the phospholipid vesicle did not vary
in this pH range. It is apparent that there are no groups
involved in protein-phospholipid interaction that ionize be-
tween pH 7 and 9. This is partially expected from the ioni-
zation groups found in phosphatidylserine (Hauser et al',
1976). It also implies that no groups in factor Va-LC are
involved in protein-lipid interaction that substantially ionize
between pH 7 and 9. This observation is consistent with an
isoelectric point of factor Va-LC higher than 9.0.
In case of phosphatidic acid, pH has a major effect on the
dissociation constants of protein-phospholipid interaction' The
protein-binding capacity of the vesicle did not vary between
pH 7 and 9. In addition, the protein-binding affinities de-
termined at pH 9 are similar to those of phosphatidylserine'
v o L .  2 2 ,  N O .  1 0 ,  1 9 8 3  2 4 3 1
Table III: Factor Va-Phospholipidd Binding to Vesicles at
Varying lonic Strength
lNaCll (M) Kd (M) n b
F
o  1 0
I
=
t'
Y 6
80
73
83
0.0s
0.1
0.5
2.2 x l0-8
6 .0  x  10-8
32.0  x  10-8
a 20%DoPSl8}%DOPC.
saturation (mol/mol).
b Phospholipid to protein ratio at
These results indicate that monovalent phosphatidic acid' pK2
- 7,has a reduced efficacy in factor Va and factor Va-LC
binding as compared to divalent phosphatidic acid and
phosphatidylserine. Taking these results together, it appears
that surface-charge density is of prime importance for factor
Va-phospholipid interaction.
Effect of lonic Strength on Factor Ya-Phospholipid In-
teraction. Sensitivity to ionic strength is considered to be
indicative for electrostatic interaction' Therefore, we studied
the effect of NaCl cgncentration on factor Va-phospholipid
interaction. Binding experiments were performed with
large-volume vesicles of 20Vo DOPS (30 pM) in 50 mM Tris-l
mM CaCl2-l mg of ovalbumin/ml (pH 7.5) and varying
NaCl concentrations. The binding parameters are shown in
Table III. As anticipated for an ionic interaction, ionic
strength has a major effect on the binding affinity. Since the
maximum protein-binding capacity of the phospholipid vesicle
is unaffected by ionic strength, it is apparent that factor Va
competes with Na+ for the same binding sites' Consistent with
the 103-fold higher affinity of Ca2+ for phosphatidylserine than
that of Na+ (Hauser et al., 1976) is the difference in the Ca2+
and Na+ concentration required to compete with factor Va
for phospholipid-binding sites. It further indicates that charge
neutralization of the phospholipid surface by 
'screening" or
"binding" of monovalent cations or divalent cations, respec-
tively, to the surface (Puskin & Martin, 1979) is accompanied
by the very same modulation of factor Va-membrane inter-
action.
Discussion
At present, it is not possible to ascertain how factor Va-
phospholipid interaction occurs. It has been suggested that
factor V and factor Va bind to phospholipid vesicles by a
nonelectrostatic interaction (Bloom et al.,1979). On the other
hand, the possibility has been addressed that factor V contains
some positively charged areas responsible for the binding to
negatively charged phospholipid (Subbaiah eL al.,1976).
In this study it is demonstrated that RW-V-activated factor
Va consists of an acidic and basic polypeptide. It is shown
that the basic factor Va subunit, which has a net positive
charge below pH 9, binds to phospholipid, whereas the acidic
factor Va subunit is unable to bind to phospholipid. It is
apparent that intact tertiary factor Va structure is not required
to form the phospholipid-binding region of factor Va, since
the equilibrium constants for thrombin-activated Va-, RW-
V-activated factor Va-, and basic factor Va subunit-
phospholipid interactions are identical.
Factor Va and the basic factor Va subunit did not bind to
phospholipid vesicles containing solely phospholipid in its
zwitterion state (e.g., phosphatidylcholine). However, the
affinities of the proteins for vesicles increase with phospha-
tidylserine content. With respect to the dependency of max-
imum protein-binding capacity of the vesicle on the mole
fraction of phosphatidylserine, it has to be mentioned that this
binding parameter is relatively insensitive to changes in
phosphatidylserine content.
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Lateral phase separation of phosphatidylserine molecules
in the membrane would be accompanied by a positive free
energy. An interesting question is whether lateral phase
separation, as the result of factor Va-phospholipid interaction,
is a major factor to the observed increase in K6 as the phos-
phatidylserine content decreases. Further studies are required
to make this clear.
The initial question we addressed in this study is does factor
Va directly interact with phosphatidylserine molecules in the
membrane. Several pieces of evidence indicate that this is the
case. Competition for the factor Va and basic factor Va
subunit binding site on the phospholipid vesicle come from
divalent cations (e.g., Ca2+). This is clearly demonstrated by
the linear relationship between the apparent Ka for factor Va-
and basic factor Va subunit-membrane interaction and cal-
cium concentration (see Figure 3). Since Ca2+-phosphati-
dylserine interaction is an ionic process, it is feasible to con-
clude that phosphatidylserine molecules are directly involved
in an electrostatic factor Va-membrane interaction. Addi-
tional evidence came from pH and ionic strength studies. The
effects of phospholipid charge neutralization are consistent with
the proposed electrostatic protein-phospholipid interaction.
That is, protonation of divalent phosphatidic acid results in
a decrease in affinity of factor Va, whereas maximum pro-
tein-binding capacity is unaffected. Apparently, the pKvalues
of the groups in the protein involved in protein-lipid interaction
did not allow establishment of charge neutralization of the
protein as a major factor to protein-lipid binding in the pH
range studied. Further studies will be required to demonstrate
unequivocally that basic amino acid residues present in the
basic factor Va subunit are involved in the interaction with
acidic phospholipids in the membrane. The ionic strength
studies reveal that factor Valhospholipid interaction has to
be viewed primarily as an ionic process. However, hydrophobic
contacts between factor Va and the hydrocarbon region of
phospholipid cannot be eliminated on the basis of our data.
After this work was completed, Pusey et al. (1982) reported
the phospholipid-binding properties offactor V. These authors
also provide evidence for an ionic interaction between protein
and phospholipid. However, their K6 values (- 16-to M) for
factor Va- and factor V-phospholipid interactions differ sig-
nificantly. Whereas the light-scattering technique used by
Pusey et al. (1982) requires a number of assumptions, our
method is direct. But for the moment, a straightforward
explanation for the discrepancy in binding data cannot be
given.
From a mechanistic standpoint, several interesting questions
arise. Since factor Va shows the characteristics ofan extrinsic
membrane protein that requires a direct interaction with
phosphatidylserine molecules in the membrane, factor Va
probably competes with prothrombin, factor X, factor Xa, and
factor V for membrane-binding sites. Whether or not this
might affect the kinetics of prothrombin activation will depend
on a variety of parameters, like the number of available
phospholipid-binding sties (e.g., phosphatidylserine molecules),
the respective protein concentrations, and specific high-affinity
protein-protein interactions [e.g., factor Va-factor Xa complex
formation (Lindhout et al., 1982)1.
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